Results 151 to 160 of about 143,361 (253)
Long‐term proton pump inhibitor (PPI) therapy raises significant concerns regarding cost‐effectiveness and adverse effects, necessitating effective deprescribing strategies. An evaluation of 763 Southeast Asian healthcare providers revealed two distinct prescriber phenotypes, where a proactive cluster utilized diverse, guideline‐based rationalization ...
Duc Trong Quach +15 more
wiley +1 more source
ABSTRACT Background and Aims Faecal microbiota transplantation (FMT) is increasingly used. However, no systematic approach exists to assess infectious risks after FMT, leading to underreporting. We evaluated infectious complications at the Netherlands Donor Feces Bank (NDFB) and proposed a structured biovigilance approach aligned with the EU Regulation
V. O. Chernova +10 more
wiley +1 more source
In reservoir‐associated RT033 strains, we observe a natural rewiring of spore germination that lowers the activation threshold and broadens bile‐salt specificity, enabling germination at low germinant levels and in response to typically inhibitory bile‐salts common in animal hosts.
Isabel Roseiro +7 more
wiley +1 more source
A Refined Method for Fecal Microbiota Transplantation Using Nutella
ABSTRACT Fecal microbiota transplantation (FMT) in mice is an evolving research field, often employing oral gavage, which can be stressful and harmful for the animals and time‐consuming for technicians. Voluntary intake methods, such as delivery in Nutella, have successfully been used for drug administration in mice and may likewise be a promising tool
Ida W. Henriksen +6 more
wiley +1 more source
Rationalizing Proton Pump Inhibitor Use: Southeast Asia Consensus Recommendations
ABSTRACT Background and Aim Proton pump inhibitors (PPIs) are integral to managing many gastrointestinal conditions. However, the prevalent inappropriate PPI prescription across Southeast Asia (SEA) is concerning. Given the absence of locally tailored recommendations to inform clinical practice, this consensus document aims to provide recommendations ...
Somchai Leelakusolvong +13 more
wiley +1 more source
ABSTRACT The lack of a dose–response model for Clostridioides difficile, attributed to insufficient human data, challenges effective C. difficile infection (CDI) risk management. This study presents a novel murine‐derived dose–response model for C.
Elizabeth N. Paddy +2 more
wiley +1 more source
Microbiota Medicine Research, Volume 1, Issue 2, Page 37-40, June 2026.
Rui Wang, Pan Li, Chen Lu, Faming Zhang
wiley +1 more source
Microbiota Medicine Research, Volume 1, Issue 2, Page 41-44, June 2026.
Quan Wen +9 more
wiley +1 more source
Predictors of Recurrent <i>Clostridioides difficile</i> Infection. [PDF]
Todor SB +6 more
europepmc +1 more source

